Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 203

1.

Conversion From Immediate-Release Tacrolimus to Prolonged-Release Tacrolimus in Stable Heart Transplant Patients: A Retrospective Study.

González-Vílchez F, Delgado JF, Palomo J, Mirabet S, Díaz-Molina B, Almenar L, Arizón JM, Rangel-Sousa D, Pérez-Villa F, Garrido IP, de la Fuente L, Gómez-Bueno M, Sanz ML, Crespo-Leiro MG.

Transplant Proc. 2019 Jul - Aug;51(6):1994-2001. doi: 10.1016/j.transproceed.2019.04.028. Epub 2019 Jun 18.

2.

Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.

Romero S, Montoro J, Guinot M, Almenar L, Andreu R, Balaguer A, Beneyto I, Espí J, Gómez-Codina J, Iacoboni G, Jarque I, López-Andújar R, Mayordomo-Aranda E, Montalar J, Pastor A, Pastor M, Piñana JL, Rojas-Ferrer N, Sánchez-Lázaro I, Sandoval J, Sanz G, Sanz MÁ, Solé A, Sanz J.

Leuk Lymphoma. 2019 Jan;60(1):142-150. doi: 10.1080/10428194.2018.1474462. Epub 2018 Jul 3.

PMID:
29966464
3.

Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design.

Miñana G, Cardells I, Palau P, Llàcer P, Fácila L, Almenar L, López-Lereu MP, Monmeneu JV, Amiguet M, González J, Serrano A, Montagud V, López-Vilella R, Valero E, García-Blas S, Bodí V, de la Espriella-Juan R, Sanchis J, Chorro FJ, Bayés-Genís A, Núñez J; Myocardial-IRON Investigators.

Clin Cardiol. 2018 Jun;41(6):729-735. doi: 10.1002/clc.22956. Epub 2018 Jun 5.

4.

Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial.

Comín-Colet J, Manito N, Segovia-Cubero J, Delgado J, García Pinilla JM, Almenar L, Crespo-Leiro MG, Sionis A, Blasco T, Pascual-Figal D, Gonzalez-Vilchez F, Lambert-Rodríguez JL, Grau M, Bruguera J; LION-HEART Study Investigators.

Eur J Heart Fail. 2018 Jul;20(7):1128-1136. doi: 10.1002/ejhf.1145. Epub 2018 Feb 6.

5.

Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.

Aguado JM, Silva JT, Fernández-Ruiz M, Cordero E, Fortún J, Gudiol C, Martínez-Martínez L, Vidal E, Almenar L, Almirante B, Cantón R, Carratalá J, Caston JJ, Cercenado E, Cervera C, Cisneros JM, Crespo-Leiro MG, Cuervas-Mons V, Elizalde-Fernández J, Fariñas MC, Gavaldà J, Goyanes MJ, Gutiérrez-Gutiérrez B, Hernández D, Len O, López-Andujar R, López-Medrano F, Martín-Dávila P, Montejo M, Moreno A, Oliver A, Pascual A, Pérez-Nadales E, Román-Broto A, San-Juan R, Serón D, Solé-Jover A, Valerio M, Muñoz P, Torre-Cisneros J; Spanish Society of Transplantation (SET); Group for Study of Infection in Transplantation of the Spanish Society of Infectious Diseases and Clinical Microbiology (GESITRA-SEIMC); Spanish Network for Research in Infectious Diseases (REIPI) (RD16/0016).

Transplant Rev (Orlando). 2018 Jan;32(1):36-57. doi: 10.1016/j.trre.2017.07.001. Epub 2017 Jul 26. Review.

PMID:
28811074
6.

Efficacy and Safety of de Novo and Early Use of Extended-release Tacrolimus in Heart Transplantation.

González-Vílchez F, Lambert JL, Rangel D, Almenar L, de la Fuente JL, Palomo J, Díaz Molina B, Lage E, Sánchez Lázaro I, Vázquez de Prada JA.

Rev Esp Cardiol (Engl Ed). 2018 Jan;71(1):18-25. doi: 10.1016/j.rec.2017.03.014. Epub 2017 May 23. English, Spanish.

PMID:
28545984
7.

Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic-refractory congestive heart failure: the SEMI-SEC project.

Pose A, Almenar L, Gavira JJ, López-Granados A, Blasco T, Delgado J, Aramburu O, Rodríguez A, Manzano L, Manito N.

ESC Heart Fail. 2017 May;4(2):130-137. doi: 10.1002/ehf2.12124. Epub 2017 Jan 19.

8.

Hyponatraemia and congestive heart failure refractory to diuretic treatment. Utility of tolvaptan.

Pose A, Almenar L, Manzano L, Gavira JJ, López Granados A, Delgado J, Aramburu O, Arévalo JC, Méndez M, Comín J, Manito N.

Rev Clin Esp. 2017 Oct;217(7):398-404. doi: 10.1016/j.rce.2017.02.013. Epub 2017 Apr 1. English, Spanish.

PMID:
28372784
9.

Activation of α1A -adrenoceptors desensitizes the rat aorta response to phenylephrine through a neuronal NOS pathway, a mechanism lost with ageing.

Arce C, Vicente D, Segura V, Flacco N, Montó F, Almenar L, Agüero J, Rueda J, Jiménez-Altayó F, Vila E, Noguera MA, D'Ocon P, Ivorra MD.

Br J Pharmacol. 2017 Jul;174(13):2015-2030. doi: 10.1111/bph.13800. Epub 2017 May 10.

10.

Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study.

Sarmiento E, Jaramillo M, Calahorra L, Fernandez-Yañez J, Gomez-Sanchez M, Crespo-Leiro MG, Paniagua M, Almenar L, Cebrian M, Rabago G, Levy B, Segovia J, Gomez-Bueno M, Lopez J, Mirabet S, Navarro J, Rodriguez-Molina JJ, Fernandez-Cruz E, Carbone J.

J Heart Lung Transplant. 2017 May;36(5):529-539. doi: 10.1016/j.healun.2016.10.004. Epub 2016 Oct 17.

PMID:
27866926
11.

Spanish Heart Transplantation Registry. 27th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2015).

González-Vílchez F, Segovia Cubero J, Almenar L, Crespo-Leiro MG, Arizón JM, Sousa I, Delgado J, Roig E, Sobrino JM, González-Costello J; Spanish Heart Transplant Teams.

Rev Esp Cardiol (Engl Ed). 2016 Nov;69(11):1071-1082. doi: 10.1016/j.rec.2016.07.010. Epub 2016 Oct 1. English, Spanish. Erratum in: Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12 ):1154-1155.

PMID:
27707562
12.

Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.

Torre-Cisneros J, Aguado JM, Caston JJ, Almenar L, Alonso A, Cantisán S, Carratalá J, Cervera C, Cordero E, Fariñas MC, Fernández-Ruiz M, Fortún J, Frauca E, Gavaldá J, Hernández D, Herrero I, Len O, Lopez-Medrano F, Manito N, Marcos MA, Martín-Dávila P, Monforte V, Montejo M, Moreno A, Muñoz P, Navarro D, Pérez-Romero P, Rodriguez-Bernot A, Rumbao J, San Juan R, Vaquero JM, Vidal E; Spanish Society of Transplantation (SET); Group for Study of Infection in Transplantation of the Spanish Society of Infectious Diseases and Clinical Microbiology (GESITRA-SEIMC); Spanish Network for Research in Infectious Diseases (REIPI).

Transplant Rev (Orlando). 2016 Jul;30(3):119-43. doi: 10.1016/j.trre.2016.04.001. Epub 2016 Apr 29. Review.

PMID:
27132815
13.

Health-related Quality of Life of Patients With Chronic Systolic Heart Failure in Spain: Results of the VIDA-IC Study.

Comín-Colet J, Anguita M, Formiga F, Almenar L, Crespo-Leiro MG, Manzano L, Muñiz J, Chaves J, de Frutos T, Enjuanes C; VIDA-IC (Quality of Life and Heart Failure in Spain: Current Situation) multicenter study researchers.

Rev Esp Cardiol (Engl Ed). 2016 Mar;69(3):256-71. doi: 10.1016/j.rec.2015.07.030. Epub 2015 Dec 23.

PMID:
26725973
14.

Cancer Incidence in Heart Transplant Recipients With Previous Neoplasia History.

Delgado JF, Alonso-Pulpón L, Mirabet S, Almenar L, Villa FP, González-Vílchez F, Palomo J, Blasco T, Dolores García-Cosio M, González-Costello J, de la Fuente L, Rábago G, Lage E, Pascual D, Molina BD, Arizón JM, Muñiz J, Crespo-Leiro MG.

Am J Transplant. 2016 May;16(5):1569-78. doi: 10.1111/ajt.13637. Epub 2016 Feb 3.

15.

Spanish Heart Transplantation Registry. 26th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2014).

González-Vílchez F, Segovia Cubero J, Almenar L, Crespo-Leiro MG, Arizón JM, Villa A, Delgado J, Roig E, Lage E, González-Costello J; Spanish Heart Transplantation Teams.

Rev Esp Cardiol (Engl Ed). 2015 Nov;68(11):1008-21. doi: 10.1016/j.rec.2015.07.009. Epub 2015 Oct 9.

PMID:
26454531
16.

β2- and β1-Adrenoceptor Expression Exhibits a Common Regulatory Pattern With GRK2 and GRK5 in Human and Animal Models of Cardiovascular Diseases.

Montó F, Oliver E, Vicente D, Buendía F, Rueda J, Agüero J, Almenar L, Valldecabres C, Rovira E, Muedra V, Noguera MA, Ivorra MD, DʼOcon P.

J Cardiovasc Pharmacol. 2015 Nov;66(5):478-86. doi: 10.1097/FJC.0000000000000299.

PMID:
26248277
17.

Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation.

Sánchez-Lázaro I, Herrero MJ, Jordán-De Luna C, Bosó V, Almenar L, Rojas L, Martínez-Dolz L, Megías-Vericat JE, Sendra L, Miguel A, Poveda JL, Aliño SF.

Pharmacogenomics. 2015;16(9):971-9. doi: 10.2217/pgs.15.39. Epub 2015 Jun 24.

PMID:
26107754
18.

Health-related quality of life, social support, and caregiver burden between six and 120 months after heart transplantation: a Spanish multicenter cross-sectional study.

Delgado JF, Almenar L, González-Vilchez F, Arizón JM, Gómez M, Fuente L, Brossa V, Fernández J, Díaz B, Pascual D, Lage E, Sanz M, Manito N, Crespo-Leiro MG.

Clin Transplant. 2015 Sep;29(9):771-80. doi: 10.1111/ctr.12578. Epub 2015 Jul 14.

PMID:
26074358
19.

Gene expression network analysis reveals new transcriptional regulators as novel factors in human ischemic cardiomyopathy.

Herrer I, Roselló-Lletí E, Ortega A, Tarazón E, Molina-Navarro MM, Triviño JC, Martínez-Dolz L, Almenar L, Lago F, Sánchez-Lázaro I, González-Juanatey JR, Salvador A, Portolés M, Rivera M.

BMC Med Genomics. 2015 Mar 29;8:14. doi: 10.1186/s12920-015-0088-y.

20.

RNA sequencing analysis identifies new human collagen genes involved in cardiac remodeling.

Gil-Cayuela C, Rivera M, Ortega A, Tarazón E, Triviño JC, Lago F, González-Juanatey JR, Almenar L, Martínez-Dolz L, Portolés M.

J Am Coll Cardiol. 2015 Mar 31;65(12):1265-1267. doi: 10.1016/j.jacc.2015.01.029. No abstract available.

21.

Heart transplantation using allografts from older donors: Multicenter study results.

Roig E, Almenar L, Crespo-Leiro M, Segovia J, Mirabet S, Delgado J, Pérez-Villa F, Luís Lambert J, Teresa Blasco M, Muñiz J; rest of the participants of the Spanish Heart Transplantation Registry.

J Heart Lung Transplant. 2015 Jun;34(6):790-6. doi: 10.1016/j.healun.2014.10.006. Epub 2014 Nov 4.

PMID:
25499140
22.

Spanish Heart Transplantation Registry. 25th official report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2013).

González-Vílchez F, Gómez-Bueno M, Almenar L, Crespo-Leiro MG, Arizón JM, Palomo J, Delgado J, Roig E, Lage E, Manito N; Spanish Heart Transplantation Teams.

Rev Esp Cardiol (Engl Ed). 2014 Dec;67(12):1039-51. doi: 10.1016/j.rec.2014.09.005. Epub 2014 Nov 11.

PMID:
25455756
23.

Donor/recipient sex mismatch and survival after heart transplantation: only an issue in male recipients? An analysis of the Spanish Heart Transplantation Registry.

Martinez-Selles M, Almenar L, Paniagua-Martin MJ, Segovia J, Delgado JF, Arizón JM, Ayesta A, Lage E, Brossa V, Manito N, Pérez-Villa F, Diaz-Molina B, Rábago G, Blasco-Peiró T, De La Fuente Galán L, Pascual-Figal D, Gonzalez-Vilchez F; Spanish Registry of Heart Transplantation.

Transpl Int. 2015 Mar;28(3):305-13. doi: 10.1111/tri.12488. Epub 2014 Nov 27.

24.

Current situation of management of systolic heart failure in Spain: VIDA-IC study results.

Anguita M, Comin-Colet J, Formiga F, Almenar L, Crespo-Leiro M, Manzano L; Investigators of the VIDA–IC Study.

Rev Esp Cardiol (Engl Ed). 2014 Sep;67(9):769-70. doi: 10.1016/j.rec.2014.03.014. Epub 2014 Jun 27. No abstract available.

PMID:
25172077
25.

Use of a "CNI holidays" strategy in acute renal dysfunction late after heart transplant. Report of two cases.

Alonso P, Sanchez-Lazaro I, Almenar L, Martinez-Dolz L, Andres A, Salvador A, Montero A.

Heart Int. 2014 Sep 1;9(2):74-7. eCollection 2014 Jul-Dec.

26.

Update on heart failure, heart transplant, congenital heart disease, and clinical cardiology.

Almenar L, Zunzunegui JL, Barón G, Carrasco JI, Gómez-Doblas JJ, Comín J, Barrios V, Subirana MT, Díaz-Molina B.

Rev Esp Cardiol (Engl Ed). 2013 Apr;66(4):290-7. doi: 10.1016/j.rec.2012.10.018. Epub 2013 Jan 12. Review.

PMID:
24775619
27.

Spanish Heart Transplantation Registry. 24th official report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2012).

González-Vílchez F, Gómez-Bueno M, Almenar L, Crespo-Leiro MG, Arizón JM, Martínez-Sellés M, Delgado J, Roig E, Lage E, Manito N; Spanish Heart Transplant Teams.

Rev Esp Cardiol (Engl Ed). 2013 Dec;66(12):973-82. doi: 10.1016/j.rec.2013.08.004. Epub 2013 Oct 25.

PMID:
24774110
28.

The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.

Roman A, Manito N, Campistol JM, Cuervas-Mons V, Almenar L, Arias M, Casafont F, del Castillo D, Crespo-Leiro MG, Delgado JF, Herrero JI, Jara P, Morales JM, Navarro M, Oppenheimer F, Prieto M, Pulpón LA, Rimola A, Serón D, Ussetti P; ATOS working group.

Transplant Rev (Orlando). 2014 Apr;28(2):84-91. doi: 10.1016/j.trre.2014.01.001. Epub 2014 Jan 27. Review.

PMID:
24602805
29.

Chronic renal dysfunction in maintenance heart transplant patients: the ICEBERG study.

González-Vílchez F, Arizón JM, Segovia J, Almenar L, Crespo-Leiro MG, Palomo J, Delgado JF, Mirabet S, Rábago G, Pérez-Villa F, Díaz B, Sanz ML, Pascual D, de la Fuente L, Guinea G; ICEBERG Study Group.

Transplant Proc. 2014 Jan-Feb;46(1):14-20. doi: 10.1016/j.transproceed.2013.09.031.

PMID:
24507019
30.

Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: calcineurin-inhibitors conversion or minimization?

Gonzalez-Vilchez F, Vazquez de Prada JA, Paniagua MJ, Gomez-Bueno M, Arizon JM, Almenar L, Roig E, Delgado J, Lambert JL, Perez-Villa F, Sanz-Julve ML, Crespo-Leiro M, Segovia J, Lopez-Granados A, Martinez-Dolz L, Mirabet S, Escribano P, Diaz-Molina B, Farrero M, Blasco T.

Int J Cardiol. 2014 Jan 15;171(1):15-23. doi: 10.1016/j.ijcard.2013.11.036. Epub 2013 Nov 23.

PMID:
24309084
31.

Primary graft failure after heart transplantation: characteristics in a contemporary cohort and performance of the RADIAL risk score.

Cosío Carmena MD, Gómez Bueno M, Almenar L, Delgado JF, Arizón JM, González Vilchez F, Crespo-Leiro MG, Mirabet S, Roig E, Pérez Villa F, Fernández-Yañez JF, Lambert JL, Manito N, Fuente L, Sanz Julve ML, Pascual D, Rábago G, Millán I, Alonso-Pulpón LA, Segovia J.

J Heart Lung Transplant. 2013 Dec;32(12):1187-95. doi: 10.1016/j.healun.2013.08.004.

PMID:
24263021
32.

Genotype and allele frequencies of drug-metabolizing enzymes and drug transporter genes affecting immunosuppressants in the Spanish white population.

Bosó V, Herrero MJ, Buso E, Galán J, Almenar L, Sánchez-Lázaro I, Sánchez-Plumed J, Bea S, Prieto M, García M, Pastor A, Sole A, Poveda JL, Aliño SF.

Ther Drug Monit. 2014 Apr;36(2):159-68. doi: 10.1097/FTD.0b013e3182a94e65.

PMID:
24232128
33.

National Consensus on the Diagnosis, Risk Stratification and Treatment of Patients with Pulmonary Embolism. Spanish Society of Pneumology and Thoracic Surgery (SEPAR). Society Española Internal Medicine (SEMI). Spanish Society of Thrombosis and Haemostasis (SETH). Spanish Society of Cardiology (ESC). Spanish Society of Medicine Accident and Emergency (SEMES). Spanish Society of Angiology and Surgery Vascular (SEACV).

Uresandi F, Monreal M, García-Bragado F, Domenech P, Lecumberri R, Escribano P, Zamorano JL, Jiménez S, Ruiz-Artacho P, Lozano F, Romera A, Jiménez D; National Consensus on Diagnosis, Risk Stratification and Treatment of Patients With Pulmonary Thromboembolism, Bellmunt S, Cuenca J, Fernández Á, Fernández F, Ibáñez V, Lozano F, March JR, Romera A, Almenar L, Castro A, Escribano P, Lázaro M, Luis Zamorano J, Alonso JR, Ramón Casal J, Miguel Franco J, Jiménez S, Merlo M, Perales R, Piñera P, Ruiz-Artacho P, Suero C, Barba R, Fernández-Capitán C, García-Bragado F, Gómez V, Monreal M, Nieto JA, Riera-Mestre A, Suárez C, Trujillo-Santos J, Conget F, Jara L, Jiménez D, Lobo JL, de Miguel J, Nauffal D, Oribe M, Otero R, Uresandi F, Domenech P, González-Porras JR, Lecumberri R, Llamas P, Mingot E, Pina E, Rodríguez-Martorell J; : Spanish Society of Pneumology and Thoracic Surgery (SEPAR); Society Española Internal Medicine (SEMI); Spanish Society of Thrombosis and Haemostasis (SETH); Spanish Society of Cardiology (ESC); Spanish Society of Medicine Accident and Emergency (SEMES); Spanish Society of Angiology and Surgery Vascular (SEACV).

Arch Bronconeumol. 2013 Dec;49(12):534-47. doi: 10.1016/j.arbres.2013.07.008. Epub 2013 Sep 14. No abstract available.

34.

Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation.

González-Vílchez F, Vázquez de Prada JA, Paniagua MJ, Almenar L, Mirabet S, Gómez-Bueno M, Díaz-Molina B, Arizón JM, Delgado J, Pérez-Villa F, Crespo-Leiro MG, Martínez-Dolz L, Roig E, Segovia J, Lambert JL, Lopez-Granados A, Escribano P, Farrero M.

Clin Transplant. 2013 Nov-Dec;27(6):E649-58. doi: 10.1111/ctr.12241. Epub 2013 Sep 12.

PMID:
24025040
35.

Myocardial and lymphocytic expression of eNOS and nNOS before and after heart transplantation: relationship to clinical status.

Vicente D, Montó F, Oliver E, Buendía F, Rueda J, Agüero J, Almenar L, Barettino D, D'Ocon P.

Life Sci. 2013 Jul 30;93(2-3):108-15. doi: 10.1016/j.lfs.2013.05.025. Epub 2013 Jun 11.

PMID:
23770231
36.

Cost-effectiveness analysis of cardiac resynchronization therapy in patients with NYHA I and NYHA II heart failure in Spain.

Almenar L, Díaz B, Quesada A, Crespo C, Martí B, Mealing S, Linde C, Daubert C.

Int J Technol Assess Health Care. 2013 Apr;29(2):140-6. doi: 10.1017/S0266462313000123. Epub 2013 Apr 3.

PMID:
23552131
37.

Spanish registry on heart transplantation. 23rd official report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2011).

Almenar L, Segovia J, Crespo-Leiro MG, Palomo J, Arizón JM, González-Vílchez F, Delgado J; Spanish Heart Transplantation Teams.

Rev Esp Cardiol (Engl Ed). 2012 Nov;65(11):1030-8. doi: 10.1016/j.recesp.2012.07.012. Epub 2012 Sep 29. English, Spanish.

PMID:
23026123
38.

Comments on the ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.

Anguita M, Comin J, Almenar L, Crespo M, Delgado J, Gonzalez-Costello J, Hernandez-Madrid A, Manito N, Perez de la Sota E, Segovia J, Segura C, Alonso-Gomez AM, Anguita M, Cequier A, Comin J, Diaz-Buschmann I, Fernandez-Lozano I, Fernandez-Ortiz A, Gomez de Diego JJ, Pan M, Worner F, Alonso-Pulpon L, Bover R, Castro A, Diaz-Molina B, Gomez-Bueno M, Gonzalez-Juanatey JR, Lage E, Lopez-Granados A, Lupon J, Martinez-Dolz L, Munoz R, Pascual D, Ridocci F, Roig E, Varela A, Vazquez de Prada JA.

Rev Esp Cardiol (Engl Ed). 2012 Oct;65(10):874-8. doi: 10.1016/j.recesp.2012.07.013. English, Spanish. No abstract available.

PMID:
22999110
39.

New concepts and best practices for management of pre- and post-transplantation cancer.

Campistol JM, Cuervas-Mons V, Manito N, Almenar L, Arias M, Casafont F, Del Castillo D, Crespo-Leiro MG, Delgado JF, Herrero JI, Jara P, Morales JM, Navarro M, Oppenheimer F, Prieto M, Pulpón LA, Rimola A, Román A, Serón D, Ussetti P; ATOS Working Group.

Transplant Rev (Orlando). 2012 Oct;26(4):261-79. doi: 10.1016/j.trre.2012.07.001. Epub 2012 Aug 15. Review.

PMID:
22902168
40.

Cross-sectional study of cardiac resynchronization therapy in Spain. Indications, implant techniques, optimization and follow-up.

Hernández-Madrid A, Matía Francés R, Moro C, Zamorano J, Almenar L, Sancho-Tello de Carranza MJ, Fernández Lozano I.

Rev Esp Cardiol (Engl Ed). 2012 Sep;65(9):826-34. Epub 2012 Jul 12. English, Spanish.

PMID:
22795364
41.

Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency.

Zuckermann A, Keogh A, Crespo-Leiro MG, Mancini D, Vilchez FG, Almenar L, Brozena S, Eisen H, Tai SS, Kushwaha S.

Am J Transplant. 2012 Sep;12(9):2487-97. doi: 10.1111/j.1600-6143.2012.04131.x. Epub 2012 Jul 9.

42.

Different expression of adrenoceptors and GRKs in the human myocardium depends on heart failure etiology and correlates to clinical variables.

Montó F, Oliver E, Vicente D, Rueda J, Agüero J, Almenar L, Ivorra MD, Barettino D, D'Ocon P.

Am J Physiol Heart Circ Physiol. 2012 Aug 1;303(3):H368-76. doi: 10.1152/ajpheart.01061.2011. Epub 2012 Jun 8.

43.

Transplantation for complex congenital heart disease in adults: a subanalysis of the Spanish Heart Transplant Registry.

Paniagua Martín MJ, Almenar L, Brossa V, Crespo-Leiro MG, Segovia J, Palomo J, Delgado J, González-Vílchez F, Manito N, Lage E, García-Guereta L, Rodríguez-Lambert JL, Albert DC.

Clin Transplant. 2012 Sep-Oct;26(5):755-63. doi: 10.1111/j.1399-0012.2012.01611.x. Epub 2012 Mar 30.

PMID:
22463464
44.

Cardiac protein changes in ischaemic and dilated cardiomyopathy: a proteomic study of human left ventricular tissue.

Roselló-Lletí E, Alonso J, Cortés R, Almenar L, Martínez-Dolz L, Sánchez-Lázaro I, Lago F, Azorín I, Juanatey JR, Portolés M, Rivera M.

J Cell Mol Med. 2012 Oct;16(10):2471-86. doi: 10.1111/j.1582-4934.2012.01565.x.

45.

Variability of NT-proBNP and its relationship with inflammatory status in patients with stable essential hypertension: a 2-year follow-up study.

Roselló-Lletí E, Calabuig JR, Morillas P, Cortés R, Martínez-Dolz L, Almenar L, González-Juanatey JR, Lauwers C, Salvador A, Portolés M, Bertomeu V, Rivera M.

PLoS One. 2012;7(2):e31189. doi: 10.1371/journal.pone.0031189. Epub 2012 Feb 23.

46.

Differences in MEF2 and NFAT transcriptional pathways according to human heart failure aetiology.

Cortés R, Rivera M, Roselló-Lletí E, Martínez-Dolz L, Almenar L, Azorín I, Lago F, González-Juanatey JR, Portolés M.

PLoS One. 2012;7(2):e30915. doi: 10.1371/journal.pone.0030915. Epub 2012 Feb 17.

47.

Impact of glomerular filtration rate on urinary BNP and NT-proBNP levels in heart failure.

Cortés R, Portolés M, Roselló-Lletí E, Martínez-Dolz L, Almenar L, Grigorian L, Bertomeu V, Rivera M.

Peptides. 2012 Feb;33(2):354-8. doi: 10.1016/j.peptides.2012.01.008. Epub 2012 Jan 20.

PMID:
22281024
48.

Myocardial G protein receptor-coupled kinase expression correlates with functional parameters and clinical severity in advanced heart failure.

Agüero J, Almenar L, Montó F, Oliver E, Sánchez-Lázaro I, Vicente D, Martínez-Dolz L, D'Ocon P, Rueda J, Salvador A.

J Card Fail. 2012 Jan;18(1):53-61. doi: 10.1016/j.cardfail.2011.10.008. Epub 2011 Nov 25.

PMID:
22196842
49.

Influence of metabolic syndrome on development of cardiac allograft vasculopathy in the transplanted heart.

Sánchez-Gómez JM, Martínez-Dolz L, Sánchez-Lázaro I, Almenar L, Sánchez-Lacuesta E, Muñoz-Giner B, Portolés M, Rivera M, Valera-Román A, González-Juanatey JR, Tejada-Ponce D, Agüero J, Buendía F, Salvador A.

Transplantation. 2012 Jan 15;93(1):106-11. doi: 10.1097/TP.0b013e3182398058.

PMID:
22134367
50.

Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation.

Gonzalez-Vilchez F, Vazquez de Prada JA, Almenar L, Arizon Del Prado JM, Mirabet S, Diaz-Molina B, Delgado JF, Gomez-Bueno M, Paniagua MJ, Perez-Villa F, Roig E, Martínez-Dolz L, Brossa V, Lambert JL, Segovia J, Crespo-Leiro MG, Ruiz-Cano MJ.

J Heart Lung Transplant. 2012 Mar;31(3):288-95. doi: 10.1016/j.healun.2011.10.011. Epub 2011 Dec 1.

PMID:
22133787

Supplemental Content

Loading ...
Support Center